TheEdgeResearch
Home / Stocks / BBRRF

Blueberries Medical Corp. (BBRRF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▼ -15.45%
Market Cap
$5.1M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.65
52-Wk Range
0.0045-0.0208
CEO
Facundo Garreton
Country
CA
Currency
USD

Blueberries Medical Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.01, down 15.45% on the session, giving a market capitalisation of $5.1M. On trailing twelve-month figures it carries a trailing P/E of -7.14, a net margin of -352.9%. Its beta of 2.65 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-7.14
Price / Sales
24.77
Price / Book
43.99
EV / EBITDA
-10.88
Gross margin
34.1%
Operating margin
-257.7%
Net margin
-352.9%
Return on equity
Debt / equity
1.35
Current ratio
0.62
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2019-02-08
Headquarters
Toronto, ON, CA
About Blueberries Medical Corp.

Blueberries Medical Corp. conducts comprehensive operations in Colombia, covering the entire process of medicinal cannabis and its derivative products—from their initial cultivation and development to final production and distribution. The company specializes in providing pharmaceutical-grade cannabis oil extracts along with other associated therapeutic products. Its corporate headquarters are situated in Bogotá, Colombia.

Comparable companies

Blueberries Medical Corp. is most often compared with the following Healthcare names:

AVTBFCANNCPIVFIONKFMVMDFPCLOFRPNRFRVVTFTHCBFVDQSF
More research on BBRRF
BBRRF technical analysis BBRRF TheEdge Score Compare against peers
Open full interactive analysis & DCF →